Mostrar el registro sencillo del ítem

dc.contributor.authorHernando Sebastian, Victoria 
dc.contributor.authorAlejos, Belén 
dc.contributor.authorMonge Corella, Susana 
dc.contributor.authorBerenguer, Juan
dc.contributor.authorAnta, Lourdes
dc.contributor.authorVinuesa, David
dc.contributor.authorPalacios, Rosario
dc.contributor.authorMuga, Roberto
dc.contributor.authorMoreno, Santiago
dc.contributor.authorJarrin-Vera, Inmaculada 
dc.date.accessioned2019-02-01T14:11:16Z
dc.date.available2019-02-01T14:11:16Z
dc.date.issued2013-08-20
dc.identifier.citationBMC Infect Dis. 2013 Aug 20;13:382.es_ES
dc.identifier.issn1471-2334es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7061
dc.description.abstractBACKGROUND: Combination antiretroviral therapy (cART) has produced significant changes in mortality of HIV-infected persons. Our objective was to estimate mortality rates, standardized mortality ratios and excess mortality rates of cohorts of the AIDS Research Network (RIS) (CoRIS-MD and CoRIS) compared to the general population. METHODS: We analysed data of CoRIS-MD and CoRIS cohorts from 1997 to 2010. We calculated: (i) all-cause mortality rates, (ii) standardized mortality ratio (SMR) and (iii) excess mortality rates for both cohort for 100 person-years (py) of follow-up, comparing all-cause mortality with that of the general population of similar age and gender. RESULTS: Between 1997 and 2010, 8,214 HIV positive subjects were included, 2,453 (29.9%) in CoRIS-MD and 5,761 (70.1%) in CoRIS and 294 deaths were registered. All-cause mortality rate was 1.02 (95% CI 0.91-1.15) per 100 py, SMR was 6.8 (95% CI 5.9-7.9) and excess mortality rate was 0.8 (95% CI 0.7-0.9) per 100 py. Mortality was higher in patients with AIDS, hepatitis C virus (HCV) co-infection, and those from CoRIS-MD cohort (1997-2003). CONCLUSION: Mortality among HIV-positive persons remains higher than that of the general population of similar age and sex, with significant differences depending on the history of AIDS or HCV coinfection.es_ES
dc.description.sponsorshipThe RIS cohort (CoRIS) is funded by the Instituto de Salud Carlos III through the Red Temática de Investigación Cooperativa en sida (RIS C03/173). This work has been partially funded by a grant from the FIS (Spanish Networks for Research on AIDS and Public Health), 04/0900 and RIS (Spanish HIV Research Network for excellence) RD06/0006. Susana Monge has been granted by Rio Ortega program (º exp CM10/00154).es_ES
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAcquired Immunodeficiency Syndrome es_ES
dc.subject.meshAdult es_ES
dc.subject.meshCohort Studies es_ES
dc.subject.meshFemale es_ES
dc.subject.meshHumans es_ES
dc.subject.meshMale es_ES
dc.subject.meshMiddle Aged es_ES
dc.subject.meshRisk Factors es_ES
dc.subject.meshSpain es_ES
dc.subject.meshYoung Adult es_ES
dc.titleAll-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID23961924es_ES
dc.format.volume13es_ES
dc.format.number1es_ES
dc.format.page382es_ES
dc.identifier.doi10.1186/1471-2334-13-382es_ES
dc.contributor.funderInstituto de Salud Carlos III 
dc.description.peerreviewedes_ES
dc.identifier.e-issn1471-2334es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/1471-2334-13-382es_ES
dc.identifier.journalBMC infectious diseaseses_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/04/0900es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD06/0006es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RIS C03/173es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional